HANSOH PHARMA (03692) released its annual performance, with Shareholder attributable profit of 4.372 billion yuan, an increase of 33.39% year-on-year, and a final dividend of 13.53 Hong Kong cents per share.

HANSOH PHARMA (03692) announced its annual performance for the year ending December 31, 2024, achieving revenue in the amount of RMB...

Zhitong FinanceMar 21 05:37 ET

Express News | Hansoh Pharmaceutical - Board Recommends a Final Dividend of HK$13.53 Cents per Share

ReutersMar 21 05:31 ET

Express News | Hansoh Pharmaceutical Group Company FY Net Income RMB 4,372 Million

ReutersMar 21 05:30 ET

Express News | Hansoh Pharmaceutical Group Company FY Revenue RMB 12,261 Million

ReutersMar 21 05:30 ET

HANSOH PHARMA: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024

HKEXMar 21 05:30 ET · Announcements

【Brokerage Focus】Zhongtai International: Hong Kong stocks are adjusting at a high level, and the Federal Reserve is slowing its balance sheet reduction.

Jinwu Financial News | On March 21, Zhongtai International's morning report stated that on March 20, the Hong Kong stock market's Large Cap experienced a high-level adjustment, with the Hang Seng Index opening at its highest point of the day, followed by a continuous decline, eventually dropping by 551 points or 2.2%, closing at 24,219 points; the Hang Seng Tech Index fell by 3.4%, closing at 5,836 points. The overall market transaction amount increased to over 294.9 billion HKD, with a net Outflow of 0.407 billion HKD from the Hong Kong Stock Connect. In terms of market performance, Hong Kong stocks faced widespread declines, with thematic stocks, heavyweights, and high-performing stocks all falling, while only a few stocks in oil, Biomedical, Marine Transportation, utilities, and Autos went against the trend and rose.

Gold Warrant Financial NewsMar 20 21:24 ET